Progyny [PGNY] vs CVS Health [CVS] Detailed Stock Comparison

Progyny Inc.

NASDAQ
Loading...

CVS Health Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Progyny Inc. wins in 8 metrics, CVS Health Corporation wins in 12 metrics, with 0 ties. CVS Health Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Progyny Inc. CVS Health Corporation Better
P/E Ratio (TTM) 27.18 55.65 Progyny Inc.
Price-to-Book Ratio 2.83 1.31 CVS Health Corporation
Debt-to-Equity Ratio 5.37 106.06 Progyny Inc.
PEG Ratio 1.09 0.72 CVS Health Corporation
EV/EBITDA 11.90 11.48 CVS Health Corporation
Profit Margin (TTM) 4.54% 0.44% Progyny Inc.
Operating Margin (TTM) 7.20% 1.57% Progyny Inc.
EBITDA Margin (TTM) 7.20% 1.57% Progyny Inc.
Return on Equity 12.48% 2.29% Progyny Inc.
Return on Assets (TTM) 8.61% 2.47% Progyny Inc.
Free Cash Flow (TTM) $191.78M $7.81B CVS Health Corporation
Dividend Yield N/A 3.23% N/A
1-Year Return 26.63% 51.14% CVS Health Corporation
Price-to-Sales Ratio (TTM) 1.12 0.25 CVS Health Corporation
Enterprise Value $1.16B $167.94B CVS Health Corporation
EV/Revenue Ratio 0.90 0.42 CVS Health Corporation
Gross Profit Margin (TTM) 24.15% 12.84% Progyny Inc.
Revenue per Share (TTM) $15 $316 CVS Health Corporation
Earnings per Share (Diluted) $0.65 $1.39 CVS Health Corporation
Beta (Stock Volatility) 0.99 0.51 CVS Health Corporation
Short % of Float 10.89% 1.56% CVS Health Corporation

Progyny Inc. vs CVS Health Corporation Stock Performance Analysis

Loading Price Chart...

PGNY
CVS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Progyny Inc.1.05%3.82%15.74%54.48%2.16%4.55%
CVS Health Corporation-1.26%3.71%5.00%32.75%26.34%25.65%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Progyny Inc.26.63%-31.61%-58.69%67.06%67.06%67.06%
CVS Health Corporation51.14%50.56%23.74%7.51%173.13%237.73%

Performance & Financial Health Analysis: Progyny Inc. vs CVS Health Corporation

MetricPGNYCVS
Market Information
Market Cap i$1.45B$101.07B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,317,2187,440,168
90 Day Avg. Volume i1,312,3267,575,109
Last Close$26.91$100.68
52 Week Range$16.10 - $28.75$58.50 - $102.77
% from 52W High-6.40%-2.03%
All-Time High$68.32 (Nov 01, 2021)$113.65 (Jul 27, 2015)
% from All-Time High-60.61%-11.41%
Growth Metrics
Quarterly Revenue Growth0.07%0.08%
Quarterly Earnings Growth0.19%0.79%
Financial Health
Profit Margin (TTM) i0.05%0.00%
Operating Margin (TTM) i0.07%0.02%
Return on Equity (TTM) i0.12%0.02%
Debt to Equity (MRQ) i5.37106.06
Cash & Liquidity
Book Value per Share (MRQ)$6.24$59.18
Cash per Share (MRQ)$3.79$8.33
Operating Cash Flow (TTM) i$210.19M$10.64B
Levered Free Cash Flow (TTM) i$212.50M$5.93B
Dividends
Last 12-Month Dividend Yield iN/A3.23%
Last 12-Month Dividend iN/A$2.68

Valuation & Enterprise Metrics Analysis: Progyny Inc. vs CVS Health Corporation

MetricPGNY (Apr 24, 2026)CVS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i27.1855.65
Forward P/E i8.419.45
PEG Ratio i1.090.72
Price to Sales (TTM) i1.120.25
Price to Book (MRQ) i2.831.31
Market Capitalization
Market Capitalization i$1.45B$101.07B
Enterprise Value i$1.16B$167.94B
Enterprise Value Metrics
Enterprise to Revenue i0.900.42
Enterprise to EBITDA i11.9011.48
Risk & Other Metrics
Beta i0.990.51
Book Value per Share (MRQ) i$6.24$59.18

Financial Statements Comparison: Progyny Inc. vs CVS Health Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPGNY (2025)CVS (2025)
Revenue/Sales i1.29B402.07B
Cost of Goods Sold i984.18M346.71B
COGS % of Revenue i76.4%86.2%
Gross Profit i304.48M55.36B
Gross Margin i23.6%13.8%
Research & Development iN/AN/A
Operating Income (EBIT) i85.28M10.39B
Operating Margin i6.6%2.6%
EBITDA i90.23M15.10B
EBITDA Margin i7.0%3.8%
Pre-Tax Income i95.43M2.14B
Pre-Tax Income % of Revenue i7.4%0.5%
Income Tax i36.91M408.00M
Income Tax % of Revenue i2.9%0.1%
Net Income (Profit) i58.52M1.73B
Profit Margin i4.5%0.4%

Balance Sheet & Liquidity Metrics

MetricPGNY (2025)CVS (2025)
Cash & Equivalents i112.24M8.45B
Total Current Assets i551.78M74.71B
Total Current Assets % of Revenue i42.8%18.6%
Total Current Liabilities i202.39M88.69B
Total Current Liabilities % of Revenue i15.7%22.1%
Long-Term Debt i24.00M74.15B
Long-Term Debt % of Revenue i1.9%18.4%
Total Shareholders Equity i516.04M75.38B
Retained Earnings i202.83M61.20B
Retained Earnings % of Revenue i15.7%15.2%
Property, Plant & Equipment i24.99M14.97B

Cash Flow Statement Comparison

MetricPGNY (2025)CVS (2025)
Operating Cash Flow i201.98M5.15B
Operating Cash Flow % of Revenue i15.7%1.3%
Capital Expenditures i-18.41M-2.83B
Free Cash Flow i191.78M7.81B
FCF Margin i14.9%1.9%
Debt Repayment iN/A-5.75B
Common Stock Repurchase i-81.66M0

Short Interest & Institutional Ownership Analysis

MetricPGNYCVS
Shares Short i6.08M19.89M
Short Ratio i3.782.56
Short % of Float i10.89%1.56%
Shares Outstanding i83.37M1.27B
Float Shares i74.96M1.27B
% Held by Insiders i1.91%0.07%
% Held by Institutions i114.23%90.07%
% Held by Public i-16.14%9.86%

Dividend Analysis & Yield Comparison: Progyny Inc. vs CVS Health Corporation

MetricPGNYCVS
Last 12-Month Dividend iN/A$2.68
Last 12-Month Dividend Yield iN/A3.23%
3-Year Avg Annual Dividend iN/A$2.61
3-Year Avg Dividend Yield iN/A0.97%
3-Year Total Dividends iN/A$7.83
Ex-Dividend DateN/AJan 22, 2026